Form 3 MICROVISION, INC. For: Jun 05 Filed by: Smith Jada
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 3 MICROVISION, INC. For: Jun 05 Filed by: Schabert Peter
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 Aerovate Therapeutics, For: Jun 05 Filed by: RA Capital Healthcare Fund LP
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13D Target Global Acquisitio Filed by: CIIG MANAGEMENT III LLC
UNITED STATESSECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
________________________
TARGET GLOBAL ACQUISITION I CORP.
(Name of Issuer)
Class A Ordinary Shares, par value $0.0001 per share
(Title of Class of Securities)
G8675N109
(CUSIP Number)
Michael Minnick
CIIG Management III LLC
40 West 57th Street, 29th Floor
New York, NY 10019
(212) 796-4796
(Name,... (continue reading...)
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: JONES WILLIAM A JR
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 W&T OFFSHORE INC For: Jun 05 Filed by: Williford William J
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: Rasulo James A
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: GERSTNER BRAD
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: Monteagudo Graciela
-
Form 4 W&T OFFSHORE INC For: Jun 05 Filed by: KROHN TRACY W
-
Form 4 Rubicon Technologies, For: Jun 05 Filed by: Palantir Technologies Inc.
-
Form 4 W&T OFFSHORE INC For: Jun 05 Filed by: Hartman Bart P. III
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: SIVARAMAKRISHNAN KAMAKSHI
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: Englebardt Samuel Eli
-
Form 4 DermTech, Inc. For: Jun 05 Filed by: Akhavan Ramin
-
Form 4 iHeartMedia, Inc. For: Jun 05 Filed by: MILLS CHERYL D
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: McKenna Mark C.
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: Bollinger Lisa
-
Form 4 DermTech, Inc. For: Jun 05 Filed by: Sun Kevin M
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: Fox Jennifer A.
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: Shah Nimish P
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: Gottesdiener Andrew
-
Form 4 Lucid Group, Inc. For: Jun 05 Filed by: Rawlinson Peter Dore
-
Form 4 DraftKings Inc. For: Jun 05 Filed by: Moore Jocelyn
-
Form 144/A Orion S.A. Filed by: Niewiem Sandra
-
Form 4/A TERAWULF INC. For: Jul 12 Filed by: Khan Nazar M.
-
Form 4 Apogee Therapeutics, For: Jun 05 Filed by: Harwin Peter Evan
-
Form 4 Lucid Group, Inc. For: Jun 05 Filed by: Dhingra Gagan
-
Form 4 SUNPOWER CORP For: Jun 05 Filed by: Johnston Jennifer
-
Form 4 Lucid Group, Inc. For: Jun 05 Filed by: Bach Eric
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: Sanders LaRae Lynn
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: WHITMAN BURKE W
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: PRESLEY DANIEL K
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: WHEELER CRAIG A
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: ROBERTS EIRY
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: Newell Clifford Doyle III
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: Walmsley Emma N
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: STANTON JOHN W
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: SCHARF CHARLES W
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: Rodriguez Carlos A
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: PRITZKER PENNY S
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: Mills Ronald Eugene
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: PETERSON SANDRA E
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: Bleil Lynn Dorsey
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: Mason Mark
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: MacGregor Catherine
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: List Teri
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: Johnston Hugh F
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: Kelly Michael Aaron
-
Form 4 MICROSOFT CORP For: Jun 07 Filed by: Hoffman Reid
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: McGough Patrick
-
Form 4 MICROSOFT CORP For: Jun 05 Filed by: Nadella Satya
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: SBLENDORIO GLENN
-
Form 4 COMSTOCK RESOURCES INC For: Jun 06 Filed by: Harrison Daniel S
-
Form 4 AMICUS THERAPEUTICS, For: Jun 06 Filed by: RAAB MICHAEL